CNTGF (Centogene NV) Research & Development: $13.43 Mil (TTM As of Dec. 2023)


CNTGF Centogene NV CNTGF
12 GF Score
Price $0.12
View Full Analysis

What is Centogene NV Research & Development?

Centogene NV CNTGF 12 Research & Development is $13.43 Mil as of Dec. 2023. GuruFocus rates CNTGF with a GF Score™ of 12/100.

Research & Development is the aggregate amount of research and development expenses during the year. Centogene NV's Research & Development for the six months ended in Dec. 2023 was $6.01 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $13.43 Mil.


Centogene NV  (OTCPK:CNTGF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Centogene NV Research & Development Related Terms


Centogene NV Research & Development Historical Data

* Premium members only.

The historical data trend for Centogene NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centogene NV Research & Development Chart

Centogene NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 10.66 18.17 21.81 18.53 13.48

Centogene NV Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.33 9.59 8.92 7.42 6.01
CNTGF
12GF Score
Centogene NV CNTGF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Centogene NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $13.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $13.43 Mil mean?
Centogene NV (CNTGF) has a Research & Development of $13.43 Mil as of Dec. 2023. Research and development expense is the total cost for research and development activities. View historical data on Centogene NV and its competitors.
Is Centogene NV's Research & Development too high?
Centogene NV's current Research & Development is $13.43 Mil. Overall, Centogene NV has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Centogene NV's Research & Development compare to ISPC and CHEK?
Centogene NV's Research & Development of $13.43 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Centogene NV and its competitors. Centogene NV's current Research & Development is $13.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centogene NV stock overvalued right now?
Centogene NV (CNTGF) has a current Research & Development of $13.43 Mil. The current Research & Development is $13.43 Mil. Centogene NV's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Centogene NV (CNTGF), the current Research & Development is $13.43 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Centogene NV Business Description

Address Am Strande 7, Rostock, MV, DEU, 18055
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.
12GF Score

Get the complete analysis for CNTGF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price